Cite

APA Citation

    Jørgensen, J., Servos, S., & Kefalas, P. (2018). the potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson's disease. Journal of market access & health policy, 6(1), . http://access.bl.uk/ark:/81055/vdc_100066557231.0x000009
  
Back to record